Remdesivir for the Treatment of Covid-19 — Final Report
Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory trac...
Publications
4 shownEpidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required sup...
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably amon...
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
In patients with severe Covid-19 not requiring mechanical ventilation, our trial did not show a significant difference between a 5-day course and a 10-day course of remdesivir. ...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 13,030
- Institution
- University College London
External Links
Identifiers
- ORCID
- 0000-0003-0324-0205
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.